#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4422457	F	Growth inhibition of human SK-MEL-103 cells	Homo sapiens	8	ALA4421731	cell-based format	Patent Bioactivity Data
2.	ALA4422458	F	Antitumor activity against human SK-MEL-103 cells xenografted in athymic nude mouse assessed as inhibition of tumor growth at 50 mg/kg, ip dosed daily	Homo sapiens	1	ALA4421731	organism-based format	Patent Bioactivity Data
3.	ALA4422459	F	Antitumor activity against human SK-MEL-103 cells xenografted in athymic nude mouse assessed as improvement in mouse survival at 50 mg/kg, ip dosed daily for 14 days dosed via Captisol formulation	Homo sapiens	1	ALA4421731	organism-based format	Patent Bioactivity Data
4.	ALA4422462	F	Antitumor activity against human SK-MEL-103 cells xenografted in athymic nude mouse assessed as improvement in mouse survival at 50 mg/kg, ip dosed daily for 4 days dosed via Captisol formulation	Homo sapiens	1	ALA4421731	organism-based format	Patent Bioactivity Data
5.	ALA4422463	F	Antitumor activity against human SK-MEL-103 cells xenografted in athymic nude mouse assessed as inhibition of tumor growth at 50 mg/kg, ip dosed daily for 14 days dosed via Captisol formulation relative to control	Homo sapiens	1	ALA4421731	organism-based format	Patent Bioactivity Data
6.	ALA4422464	F	Antitumor activity against human SK-MEL-103 cells xenografted in athymic nude mouse assessed as increase in doubling time for tumor growth at 50 mg/kg, ip dosed daily for 14 days dosed via Captisol formulation relative to control	Homo sapiens	1	ALA4421731	organism-based format	Patent Bioactivity Data
7.	ALA4422465	F	Antitumor activity against human SK-MEL-103 cells xenografted in athymic nude mouse assessed as growth delay time in reaching study end point (1000 mm3 tumor growth) at 50 mg/kg, ip dosed daily for 14 days dosed via Captisol formulation relative to control	Homo sapiens	1	ALA4421731	organism-based format	Patent Bioactivity Data
8.	ALA4422466	F	Antitumor activity against human SK-MEL-103 cells xenografted in athymic nude mouse assessed as initial tumor level at 50 mg/kg, ip dosed daily for 14 days dosed via Captisol formulation (Rvb = 80%)	Homo sapiens	1	ALA4421731	organism-based format	Patent Bioactivity Data
9.	ALA4842685	F	Cytotoxicity against human SK-MEL-103 cells assessed as inhibition of cell proliferation at 25 uM incubated for 72 hrs by MTT assay relative to control	Homo sapiens	17	ALA4842319	cell-based format	Scientific Literature
10.	ALA5151562	F	Cytotoxicity against human SK-MEL-103 cells assessed as cell growth inhibition measured after 24 hrs by WST-1 assay	Homo sapiens	3	ALA5149994	cell-based format	Scientific Literature